Sixteen Holstein bull calves were used to evaluate effects of increasing blood BHBA, as a consequence of ruminal development, on response of peripheral blood mononuclear cells to mitogenic stimulation. Calves were blocked by date of birth and assigned to weaning at 35 or 49 d of the study. Calves began the study at 4 d of age. Milk replacer was fed at 10% of BW to d 7 prior to weaning; thereafter, milk replacer offered was reduced by 50%. Calf starter was offered from d 1. Blood was sampled at wk 0, 2, 4, 6, 8, and 10 at 4 h after the a.m. feeding. Blood glucose declined, and blood BHBA increased, as calf starter intake increased. Blood BHBA increased at weaning in each treatment group and exceeded 1 mM during the week of weaning. Responses of peripheral blood mononuclear cells to stimulation with concanavalin A, pokeweed mitogen, or phytohemagglutinin were unaffected by increasing blood BHBA and increased with age. Increased concentration of blood BHBA in young calves from increased starter intake did not impair immune response. 
INTRODUCTION
Weaning dairy calves at 4 to 6 wk of age is a common management practice. Calf starters fed with limited forage stimulate ruminal development by increasing ruminal VFA and reducing ruminal pH (1, 12) . Low pH and high concentrations of ruminal VFA increase transport and metabolism of VFA, particularly butyrate, by ruminal epithelium (15) . Butyrate is converted to BHBA by ruminal epithelium and released to portal blood. Blood ketones increase as a result of dry feed intake with early weaning (10, 1 l), and blood BHBA may reach or exceed 1 mM by 1 to 2 wk after weaning.
The ability of peripheral blood mononuclear cells (PBMC) to respond to mitogenic challenge was reduced when PBMC were incubated in vitro with BHBA at approximately .l, 1, and 5 mM (16) or when calves were fed 1,3-butanediol to increase blood BHBA (17). Reduced response of PBMC to mitogenic challenge may indicate immune suppression and increased susceptibility to disease. Conversely, Franklin et al. (5) reported no effect of ketones when PBMC were incubated with mitogens in vitro, although inhibition of PBMC stimulated by phytohemagglutinin (PHA) and pokeweed mitogen (PWM) occurred at 6.25 mM BHBA. Also, secretion of IgM by bovine blood lymphocytes in vitro was unaffected by ketones up to 6.25 mM (8) . If BHBA concentrations, elevated as a consequence of developing ruminal function, inhibit PBMC response to mitogenic challenge, current feeding management may compromise the ability of calves to elicit an immune response. Therefore, our objective was to determine the effects of developing ruminal function and increasing blood BHBA on PBMC response to mitogenic stimulation. Ruminal development was effected by controlling age at weaning. 
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MATERIALS AND METHODS
Experimental
Sampling and Analyrlr
Body weights were measured at the initiation of the study (d 0) and every 7 d thereafter to wk 10. Blood was sampled approximately 24 h after birth, and serum IgG was measured by single radial immunodiffusion (VMRD Inc., Pullman, WA). Jugular blood (about 10 ml)
was collected approximately 4 h after the a.m. feeding at 0,2,4, 6, 8, and 10 wk of the study.
A 2-ml subsample was deproteinated immediately with 2 ml of 1 M HC104 and placed on ice prior to analysis of BHBA (19) . A second blood sample (4 ml) was deproteinated in 4 ml of 8% HC104 prior to analysis of L(+)-lactate (lactate kit 826; Sigma Chemical Co., St. Louis, MO). Remaining blood was added to 400 p1 of 6% EDTA prior to separation of plasma and analysis of glucose (glucose kit 510; Sigma Chemical Co.).
The PBMC were obtained as described by
Torre and Oliver (18) . Briefly, 10 ml of blood were collected into 100 pl of 15% EDTA and diluted 1:3 (volhol) in PBS (8 mM Na2HP04, 1.5 mM KH2PO4; pH 7.3). Diluted blood was underlaid with 10 ml of Ficoll@-sodium di- 
RESULTS AND DISCUSSION
Calves were healthy throughout the study. Prevalence of respiratory and digestive tract diseases was minimal and unrelated to treatment. Concentration of IgG in colostrum averaged 42.6 mg/ml (SE = 1.2). Mean serum IgG concentration at 24 h was 8.5 mg/ml (SE = .6), ranged from 5.6 to 13.5 mg/ml, and was unaffected by treatment.
Chemical composition of calf starter and milk replacer (Table 1) generally was similar to NRC (7) recommendations for similar feeds, although CP was higher than recommendations in both feeds.
Calf BW was unaffected by treatment, although a week x treatment interaction was significant for average daily gain ( Table 2) . Rates of gain were depressed during the week prior to weaning when milk replacer was limited to 50% of the intake of the previous week. However, by 1 wk after weaning, rates of average daily gain were similar to those prior to reduction in milk offered. Prior to and after weaning, rates of average daily gain did not differ between treatments and were typical of well-managed Holstein calves.
Starter intake (Table 2 ) and BHBA (Table 3 ) were significantly (P < .01) affected by treatment. Blood BHBA was correlated (r = .65) with starter intake and increased after weaning in both groups. Maximal BHBA was 1.17 and 1.21 mM in W35 and W49 treatment groups, respectively, at 1 wk postweaning. Rapid increases in blood BHBA have been reported (10, 11) and are associated with ruminal fermentation of high grain diets (13). Blood glucose declined at weaning and varied by treatment. Lactate was not influenced by treatment and decreased from 2.1 mM at wk 0 to 1.0 mM at wk 8. Neither blood glucose nor L(+)-lactate was correlated with PBMC response to all mitogens, although glucose was correlated (r = -.21) with PBMC response to PHA. These data indicate that moderate changes in concentration of glucose and lactate did not significantly affect PBMC response.
Response of PBMC to mitogenic challenge was unaffected by treatment (Table 4) , although response to all mitogens changed as starter intake increased. Starter intake was correlated (r = .38, .52, and .38) with PBMC response to Con A, PHA, and PWM, respecp1 of complete RPMI-1640 and 10% fetal bovine serum only. Tissue culture plates were incubated for 72 h at 37'C in an atmosphere of 95% air and 5% C02. Thereafter, 1 pCi of [methyl-3H]thymidine (ICN Radiochemicals, &ne, CA) in 50 p1 of complete RPMI-1640 was added to each well and incubated for the remaining 20 h of total incubation. The PBMC were harvested on glass fiber filters using an automated cell harvester (PHD Cell Harvester; Cambridge Technology, Inc., Watertown, MA). Retained radioactivity was counted in a liquid scintillation counter (Mark V series liquid scintillation counting system; TM Analytical Inc., Elk Grove Village, IL).
Samples of calf starter were collected weekly, composited by shipment, and analyzed for DM, CP (2), and NDF (6).
Statlstlcal Analysis
Data were analyzed as a repeated measures experimental design using a general linear mixed model algorithm (3 Block x treatment interaction was used to test effects of treatment. Significance was at P < .05 unless otherwise noted. Because calves were treated similarly until wk 5 of the study, data also were grouped by preweaning (1 to 5 wk) and periweaning (6 to 10 wk) periods and analyzed as described; however, results by weaning periods were similar to results for all weeks. 
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Glucose. Management practices to promote early weaning with rapid ruminal development and concomitant production of BHBA do not appear to affect PBMC response to mitogenic challenge negatively.
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